Barbara A. Olson

2.4k total citations · 1 hit paper
45 papers, 1.8k citations indexed

About

Barbara A. Olson is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Barbara A. Olson has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Genetics. Recurrent topics in Barbara A. Olson's work include Estrogen and related hormone effects (5 papers), Renin-Angiotensin System Studies (5 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). Barbara A. Olson is often cited by papers focused on Estrogen and related hormone effects (5 papers), Renin-Angiotensin System Studies (5 papers) and Effects and risks of endocrine disrupting chemicals (4 papers). Barbara A. Olson collaborates with scholars based in United States, Canada and United Kingdom. Barbara A. Olson's co-authors include Nicholas J. Laping, John D. Harling, Laramie M. Gaster, James A. Fornwald, Ruth Lehr, James F. Callahan, Anil Mathur, Eugene T. Grygielko, Jennifer M. Bomberger and W. Martin and has published in prestigious journals such as Technometrics, Journal of Agricultural and Food Chemistry and Journal of Applied Physiology.

In The Last Decade

Barbara A. Olson

42 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542

2002 544 citations Nicholas J. Laping, Eugene T. Grygielko et al. Molecular Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara A. Olson United States	18	886	259	246	194	162	45	1.8k
Adrian Bomford United Kingdom	38	1.0k 1.2×	289 1.1×	220 0.9×	346 1.8×	158 1.0×	109	5.9k
Kee‐Lung Chang Taiwan	28	770 0.9×	203 0.8×	218 0.9×	145 0.7×	163 1.0×	62	1.9k
Janice Barnes United States	24	1.0k 1.2×	340 1.3×	123 0.5×	68 0.4×	132 0.8×	37	1.6k
Kunihiro Hayakawa Japan	26	931 1.1×	132 0.5×	116 0.5×	188 1.0×	139 0.9×	58	2.2k
Nam Hee Won South Korea	23	705 0.8×	411 1.6×	217 0.9×	61 0.3×	89 0.5×	59	2.3k
Parvaneh Rafiee United States	29	1.1k 1.3×	436 1.7×	239 1.0×	53 0.3×	214 1.3×	51	2.6k
Yin Li United States	18	444 0.5×	143 0.6×	150 0.6×	279 1.4×	365 2.3×	30	1.9k
Ada Elgavish United States	22	797 0.9×	286 1.1×	368 1.5×	42 0.2×	338 2.1×	76	2.0k
Robert E. Fleming United States	39	1.1k 1.2×	164 0.6×	62 0.3×	227 1.2×	150 0.9×	94	5.8k
H.-J. Merker Germany	21	567 0.6×	265 1.0×	79 0.3×	164 0.8×	209 1.3×	100	1.9k

Countries citing papers authored by Barbara A. Olson

Since Specialization

Citations

This map shows the geographic impact of Barbara A. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Olson more than expected).

Fields of papers citing papers by Barbara A. Olson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Olson. The network helps show where Barbara A. Olson may publish in the future.

Co-authorship network of co-authors of Barbara A. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Olson. A scholar is included among the top collaborators of Barbara A. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Olson. Barbara A. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ralston, Brenda, et al.. (2024). Efficacy and Safety of Lidocam Topical Gel (4% Lidocaine—0.3% Meloxicam) for Pain and Inflammation Management during Castration and Tail Docking in Piglets. Animals. 14(6). 930–930.

Laping, Nicholas J., Eugene T. Grygielko, Anil Mathur, et al.. (2002). Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542. Molecular Pharmacology. 62(1). 58–64. 544 indexed citations breakdown →

Callahan, James F., Joelle L. Burgess, James A. Fornwald, et al.. (2002). Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5). Journal of Medicinal Chemistry. 45(5). 999–1001. 267 indexed citations

Hutchins, Andrea M., Margaret C. Martini, Barbara A. Olson, William I. Thomas, & Joanne Slavin. (2001). Flaxseed Consumption Influences Endogenous Hormone Concentrations in Postmenopausal Women. Nutrition and Cancer. 39(1). 58–65. 77 indexed citations

Laping, Nicholas J., Barbara A. Olson, & Yuan Zhu. (2001). Identification of a Novel Nuclear Guanosine Triphosphate-Binding Protein Differentially Expressed in Renal Disease. Journal of the American Society of Nephrology. 12(5). 883–890. 17 indexed citations

Laping, Nicholas J., Allen H. Nelson, Lisa C. Contino, et al.. (2001). Renoprotective effects of carvedilol in hypertensive‐stroke prone rats may involve inhibition of TGFβ expression. British Journal of Pharmacology. 134(5). 977–984. 32 indexed citations

Laping, Nicholas J., et al.. (2001). The role of transforming growth factor-β and its receptors in human prostate smooth muscle cell fibronectin production. European Journal of Pharmacology. 422(1-3). 47–52. 5 indexed citations

Hutchins, Andrea M., Margaret C. Martini, Barbara A. Olson, William Thomas, & Joanne Slavin. (2000). Flaxseed influences urinary lignan excretion in a dose-dependent manner in postmenopausal women.. PubMed. 9(10). 1113–8. 52 indexed citations

Wong, Victoria, Nicholas J. Laping, Lisa C. Contino, et al.. (2000). Gene expression in rats with renal disease treated with the angiotensin II receptor antagonist, eprosartan. Physiological Genomics. 4(1). 35–42. 13 indexed citations

10.

Haggans, Carol J., Andrea M. Hutchins, Barbara A. Olson, et al.. (1999). Effect of Flaxseed Consumption on Urinary Estrogen Metabolites in Postmenopausal Women. Nutrition and Cancer. 33(2). 188–195. 83 indexed citations

11.

Brooks, David P., et al.. (1999). Sgk, a Putative Serine/Threonine Kinase, Is Differentially Expressed in the Kidney of Diabetic Mice and Humans. Journal of the American Society of Nephrology. 10(12). 2488–2494. 62 indexed citations

12.

Olson, Barbara A., Jonathan Day, & Nicholas J. Laping. (1999). Age-Related Expression of Renal Thrombospondin 1 mRNA in F344 Rats: Resemblance to Diabetes-Induced Expression in Obese Zucker Rats. Pharmacology. 58(4). 200–208. 19 indexed citations

13.

Ali, Shujath M., Nicholas J. Laping, Todd A. Fredrickson, et al.. (1998). Angiotensin-Converting Enzyme Inhibition Attenuates Proteinuria and Renal TGF-β1 mRNA Expression in Rats with Chronic Renal Disease. Pharmacology. 57(1). 20–27. 17 indexed citations

14.

Laping, Nicholas J., Barbara A. Olson, Robin DeWolf, et al.. (1998). Activation of Glomerular Mesangial Cells by Hepatocyte Growth Factor Through Tyrosine Kinase and Protein Kinase C. Biochemical Pharmacology. 55(2). 227–234. 10 indexed citations

15.

Olson, Barbara A., Shujath M. Ali, Lisa C. Contino, David P. Brooks, & Nicholas J. Laping. (1998). Angiotensin-Converting Enzyme Inhibition Alters Clusterin mRNA Expression in the Kidney following Renal Mass Reduction. Pharmacology. 57(1). 13–19. 6 indexed citations

16.

Olson, Barbara A., et al.. (1997). Control Sensor Linearization Using Artificial Neural Networks. Analog Integrated Circuits and Signal Processing. 13(3). 321–332. 11 indexed citations

17.

Olson, Barbara A., et al.. (1994). Recycling Cured Phenolic Material. Journal of Thermoplastic Composite Materials. 7(1). 30–41. 7 indexed citations

18.

McCoy, D. E., et al.. (1993). The renal adenosine system: structure, function, and regulation.. PubMed. 13(1). 31–40. 51 indexed citations

19.

Lehning, Ellen J., et al.. (1989). Enhanced Withdrawal of Polychlorinated Biphenyls: A Comparison of Colestipol, Mineral Oil, Propylene Glycol, and Petroleum Jelly with or Without Restricted Feeding ,. Poultry Science. 68(7). 885–890. 9 indexed citations

20.

Olson, Barbara A. & Steven J. Bursian. (1988). Effect of route of administration on the development of organophosphate‐induced delayed neurotoxicity in 4‐week‐old chicks. Journal of Toxicology and Environmental Health. 23(4). 499–505. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact